1-3 of 3
Ryszard Wichary
Close
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

Response to Tyrosine Kinase Inhibitors Therapy and Donor Lymphocyte Infusion In Patients with Chronic Myelogenous Leukemia Relapsing After Allogenic Hematopoietic Stem Cell Transplantation.

Malgorzata Sobczyk-Kruszelnicka, Tomasz Czerw, Anna Waclawik, Ryszard Wichary, Wlodzimierz Mendrek, Slawomira Kyrcz-Krzemien, Prof, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4482.
https://doi.org/10.1182/blood.V116.21.4482.4482
Published: 2010
Journal Articles

Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia

Grzegorz Helbig, Marek Hus, Andrzej Moskwa, Krystyna Zawilska, MD, PhD, Lucyna Molendowicz-Portala, Alina Świderska, Alina Urbanowicz, Ewa ˙Zuk, Małgorzata Raźny, Marek Rodzaj, Ilona Seferyńska, Małgorzata Całbecka, Ryszard Wichary, Slawomira Kyrcz-Krzemien, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4097.
https://doi.org/10.1182/blood.V116.21.4097.4097
Published: 2010